Mani Foroohar
Stock Analyst at Leerink Partners
(0.99)
# 3,827
Out of 4,460 analysts
944
Total ratings
45%
Success rate
-0.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mani Foroohar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABSI Absci | Initiated Coverage: Buy | $12 | $11.59 | +3.54% | 1 | Jun 4, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $17 | $11.98 | +41.90% | 64 | May 15, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $100 → $154 | $117.07 | +31.55% | 54 | May 15, 2026 | |
| ENGN enGene Therapeutics | Downgraded: Hold | $14 → $2 | $1.73 | +15.61% | 13 | May 8, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | $27 → $35 | $16.92 | +106.86% | 52 | Apr 27, 2026 | |
| CAMP Camp4 Therapeutics | Maintained: Buy | $8 → $9 | $4.39 | +105.25% | 7 | Apr 2, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Hold | $7 → $11 | $3.42 | +221.64% | 55 | Mar 27, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Hold | n/a | $81.51 | - | 56 | Mar 26, 2026 | |
| MRNA Moderna | Maintained: Sell | $12 | $70.03 | -82.86% | 89 | Feb 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Hold | $370 → $351 | $301.03 | +16.60% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $100 | $79.29 | +26.12% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $86 | $74.48 | +15.47% | 76 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $2 | $0.7391 | +170.60% | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $4.66 | +286.68% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $74 | $54.54 | +35.68% | 27 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.30 | - | 41 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.67 | - | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $48 | $55.00 | -12.73% | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $13.38 | +49.48% | 9 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $34.32 | - | 20 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $27 | $16.25 | +66.15% | 12 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.76 | +70.45% | 32 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $31.45 | +122.58% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $3.24 | n/a | 20 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $4.07 | n/a | 31 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.2365 | n/a | 3 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 | $5.68 | n/a | 15 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $7.90 | n/a | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $5.81 | n/a | 24 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $6 | $6.18 | n/a | 17 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $34.38 | n/a | 7 | Oct 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $216 → $197 | $17.97 | n/a | 3 | Nov 6, 2020 |
Absci
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $11.59
Upside: +3.54%
REGENXBIO
May 15, 2026
Maintained: Buy
Price Target: $17
Current: $11.98
Upside: +41.90%
Mirum Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $100 → $154
Current: $117.07
Upside: +31.55%
enGene Therapeutics
May 8, 2026
Downgraded: Hold
Price Target: $14 → $2
Current: $1.73
Upside: +15.61%
Intellia Therapeutics
Apr 27, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $16.92
Upside: +106.86%
Camp4 Therapeutics
Apr 2, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $4.39
Upside: +105.25%
Rocket Pharmaceuticals
Mar 27, 2026
Rated: Hold
Price Target: $7 → $11
Current: $3.42
Upside: +221.64%
Arrowhead Pharmaceuticals
Mar 26, 2026
Maintained: Hold
Price Target: n/a
Current: $81.51
Upside: -
Moderna
Feb 11, 2026
Maintained: Sell
Price Target: $12
Current: $70.03
Upside: -82.86%
Alnylam Pharmaceuticals
Dec 15, 2025
Maintained: Hold
Price Target: $370 → $351
Current: $301.03
Upside: +16.60%
Dec 15, 2025
Maintained: Buy
Price Target: $68 → $100
Current: $79.29
Upside: +26.12%
Dec 15, 2025
Maintained: Buy
Price Target: $370 → $86
Current: $74.48
Upside: +15.47%
Dec 15, 2025
Maintained: Buy
Price Target: $3 → $2
Current: $0.7391
Upside: +170.60%
Oct 21, 2025
Maintained: Buy
Price Target: $20 → $18
Current: $4.66
Upside: +286.68%
Oct 15, 2025
Maintained: Buy
Price Target: $56 → $74
Current: $54.54
Upside: +35.68%
Oct 15, 2025
Maintained: Buy
Price Target: n/a
Current: $13.30
Upside: -
Oct 15, 2025
Maintained: Hold
Price Target: n/a
Current: $3.67
Upside: -
Sep 25, 2025
Maintained: Buy
Price Target: $51 → $48
Current: $55.00
Upside: -12.73%
Sep 23, 2025
Reiterated: Buy
Price Target: $20
Current: $13.38
Upside: +49.48%
Sep 3, 2025
Maintained: Buy
Price Target: n/a
Current: $34.32
Upside: -
Aug 18, 2025
Maintained: Buy
Price Target: $32 → $27
Current: $16.25
Upside: +66.15%
Aug 13, 2025
Reiterated: Buy
Price Target: $3
Current: $1.76
Upside: +70.45%
Aug 12, 2025
Reiterated: Buy
Price Target: $70
Current: $31.45
Upside: +122.58%
Mar 6, 2025
Maintained: Hold
Price Target: $1
Current: $3.24
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $1
Current: $4.07
Upside: n/a
Jul 15, 2024
Maintained: Buy
Price Target: n/a
Current: $0.2365
Upside: n/a
Nov 13, 2023
Maintained: Hold
Price Target: $21
Current: $5.68
Upside: n/a
Jun 8, 2023
Maintained: Sell
Price Target: n/a
Current: $7.90
Upside: n/a
May 23, 2023
Reiterated: Hold
Price Target: $6 → $5
Current: $5.81
Upside: n/a
Nov 14, 2022
Reiterated: Hold
Price Target: $5 → $6
Current: $6.18
Upside: n/a
Oct 19, 2021
Maintained: Hold
Price Target: n/a
Current: $34.38
Upside: n/a
Nov 6, 2020
Maintained: Buy
Price Target: $216 → $197
Current: $17.97
Upside: n/a